Recombinant Human IL-19 Protein
Beta LifeScience
SKU/CAT #: BLK-01881P-100UG

Human IL-19 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human IL-19 Protein
Beta LifeScience
SKU/CAT #: BLK-01881P-100UG
Collections: High-quality recombinant proteins, Other recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human IL-19 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Leu25-Ala177. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9UHD0 |
Target Symbol | IL-19 |
Synonyms | Interleukin-19; IL-19; ZMDA1; IL-10C; MDA1; NG.1 |
Species | Human |
Expression System | HEK293 |
Tag | C-hFc |
Expression Range | Leu25-Ala177 |
Mol. Weight | The protein has a predicted MW of 44.6 kDa. Due to glycosylation, the protein migrates to 55-60 kDa based on Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in 20mM Tris, 500mM NaCl (pH 8.0). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | Interleukin-19 (IL-19) has been shown to be involved in coronary artery diseases and atherosclerosis, while its expression in myocardial infarction is poorly understood. In this study, the dynamic increase in circulating IL-19 in acute ST-segment elevation myocardial infarction (STEMI) patients was detected.IL-19 is correlated with the severity of acute myocardial infarction, which may be a new idea for the clinical treatment of myocardial infarction. |